A Prospective, Multicentre, Multinational, Open Label, Non-Controlled, Observational, 24-Week Study in Patients Using Oral Anti-Diabetic (OAD) Drugs + Levemir (Insulin Detemir) for Treatment of Type 2 Diabetes Mellitus in Near East Region Countries
Phase of Trial: Phase III
Latest Information Update: 09 Dec 2016
At a glance
- Drugs Insulin detemir (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- Acronyms BO2NE
- 10 Jun 2017 Biomarkers information updated
- 11 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Jul 2010 Planned end date changed from 1 Apr 2010 to 1 Aug 2010 as reported by ClinicalTrials.gov.